Published in Clin Sci (Lond) on January 01, 1999
Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev (2007) 4.25
A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health (2007) 2.50
A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med (2008) 2.31
Regulation of inflammation in cancer by eicosanoids. Prostaglandins Other Lipid Mediat (2011) 1.31
Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms. Br J Cancer (2003) 1.16
Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer. Br J Cancer (2013) 1.09
Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer. Br J Cancer (2006) 1.08
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review. PLoS One (2015) 1.03
Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. Br J Cancer (2012) 0.95
Two polymorphisms of the tumour necrosis factor gene do not influence survival in pancreatic cancer. Clin Exp Immunol (1999) 0.88
Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts. Cancer Epidemiol Biomarkers Prev (2013) 0.86
Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer. PLoS One (2013) 0.86
LLL12 inhibits endogenous and exogenous interleukin-6-induced STAT3 phosphorylation in human pancreatic cancer cells. Anticancer Res (2011) 0.86
Intratumoral expression of macrophage migration inhibitory factor is correlated with serum C-reactive protein and interleukin-6 in patients with non-small cell lung cancer. Surg Today (2008) 0.85
Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease. Mol Cancer (2014) 0.85
Characterization of Mouse Models of Early Pancreatic Lesions Induced by Alcohol and Chronic Pancreatitis. Pancreas (2015) 0.80
Interaction of gonadal status with systemic inflammation and opioid use in determining nutritional status and prognosis in advanced pancreatic cancer. Support Care Cancer (2010) 0.78
Lack of knowledge: breast cancer and the soluble interleukin-6 receptor. Breast Care (Basel) (2010) 0.78
HDAC3 mediates smoking-induced pancreatic cancer. Oncotarget (2016) 0.77
F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities. Semin Cancer Biol (2016) 0.76
Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review. PLoS One (2016) 0.76
Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg (1994) 2.69
Outcome of patients with abdominal sepsis treated in an intensive care unit. Br J Surg (1995) 2.38
Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children's Cancer Group. Am J Epidemiol (1997) 2.36
Psychophysics of reading. VIII. The Minnesota Low-Vision Reading Test. Optom Vis Sci (1989) 2.21
National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health (1997) 2.17
Role of selectins in development of adult respiratory distress syndrome. Lancet (1994) 2.14
Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer (1995) 2.09
Prediction of risk in biliary surgery. Br J Surg (1983) 2.07
Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals. J Natl Cancer Inst (1987) 2.02
Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer. Br J Surg (2001) 1.96
Periconceptional maternal vitamin supplementation and childhood leukaemia: an uncertainty analysis. J Epidemiol Community Health (2008) 1.87
Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992. J Pediatr Hematol Oncol (1997) 1.87
Randomized controlled trial of the effect of early enteral nutrition on markers of the inflammatory response in predicted severe acute pancreatitis. Br J Surg (2000) 1.87
Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci (Lond) (2000) 1.74
Accidents in the workplace. J Soc Occup Med (1991) 1.71
Metabolism of 3-(p-bromophenyl)-1-methoxy-1-methylurea (metobromuron) by selected soil microorganisms. J Agric Food Chem (1970) 1.70
Trends in cancer incidence among children in the U.S. Cancer (1996) 1.69
Cytokine regulation of constitutive production of interleukin-8 and -6 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer. Int J Oncol (2002) 1.53
Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer (1997) 1.52
Laparotomy for abdominal sepsis in the critically ill. Br J Surg (1996) 1.50
Endothelial-derived selectins in the development of organ dysfunction in acute pancreatitis. Crit Care Med (2001) 1.49
Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway. J Biol Chem (2000) 1.48
Effect of eicosapentaenoic acid and other fatty acids on the growth in vitro of human pancreatic cancer cell lines. Br J Cancer (1994) 1.48
The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer (1999) 1.46
Special problems in acute laryngotracheobronchitis. Laryngoscope (1969) 1.40
Observations on the physiology of the human renal pelvis and ureter. J Urol (1967) 1.38
Clinical significance of first-trimester chorionic bumps: a matched case-control study. Ultrasound Obstet Gynecol (2013) 1.38
Isoflurane for removal of chest drains after cardiac surgery. Anaesthesia (1997) 1.37
The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition (1996) 1.34
Expectant management of missed miscarriage. Br J Obstet Gynaecol (1998) 1.32
A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg (1995) 1.32
Hepatoblastoma and birth weight: too little, too big, or just right? J Pediatr (1997) 1.31
Molecular evidence for a single clonal origin in biphenotypic concomitant chronic lymphocytic leukemia and multiple myeloma. Blood (1989) 1.28
Psychophysics of reading. Clinical predictors of low-vision reading speed. Invest Ophthalmol Vis Sci (1992) 1.27
Molecular characterization of the surface of apoptotic neutrophils: implications for functional downregulation and recognition by phagocytes. Cell Death Differ (2000) 1.26
Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: a Childrens Cancer Group study. J Natl Cancer Inst (1996) 1.26
Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. JAMA (1995) 1.25
A Method for Reclaiming Dried Zoological Specimens. Science (1947) 1.24
High birth weight and risk of specific childhood cancers: a report from the Children's Cancer Group. J Pediatr (1997) 1.24
Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg (1996) 1.23
Epidemiology of acute leukemia in children and adults. Semin Oncol (1997) 1.22
Proteolysis-inducing factor regulates hepatic gene expression via the transcription factors NF-(kappa)B and STAT3. FASEB J (2001) 1.22
Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr Cancer (1999) 1.22
Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer (2000) 1.22
Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. Am J Physiol (1997) 1.21
Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response. J Nutr (1998) 1.19
Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response. Ann Surg (1998) 1.19
Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia. World J Surg (1999) 1.16
Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Sci (Lond) (1997) 1.15
A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer. Br J Cancer (2000) 1.15
Forms and functions of CD44. Immunology (1998) 1.15
Metobromuron: acetylation of the aniline moiety as a detoxification mechanism. Science (1970) 1.13
Reduction of weight loss and tumour size in a cachexia model by a high fat diet. Br J Cancer (1987) 1.12
Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis. Br J Surg (1996) 1.11
A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. Br J Cancer (1999) 1.11
Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor. Br J Surg (2000) 1.10
Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy. Br J Cancer (2006) 1.09
Glutamine-supplemented total parenteral nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection. Ann Surg (1994) 1.09
Dibenzo[a,l]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung. Carcinogenesis (1997) 1.09
The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer (2009) 1.09
Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients. Br J Cancer (2011) 1.09
Cancer cachexia. Surg Oncol (1999) 1.09
Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer. Br J Cancer (2006) 1.08
Comparison of bio-impedance spectroscopy and multi-frequency bio-impedance analysis for the assessment of extracellular and total body water in surgical patients. Clin Sci (Lond) (1995) 1.08
Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer. Br J Cancer (2010) 1.07
Early cellular reactions induced by dinitrochlorobenzene in sensitized human skin. Br J Dermatol (1984) 1.06
Ultraviolet-irradiated urocanic acid suppresses delayed-type hypersensitivity to herpes simplex virus in mice. J Invest Dermatol (1986) 1.06
Childhood cancer in the offspring born in 1921-1984 to US radiologic technologists. Br J Cancer (2008) 1.05
Role for CD40-CD40 ligand interactions in the immune response to solid tumours. Mol Immunol (2000) 1.05
Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. Am J Physiol (1995) 1.03
Role of serum endotoxin and antiendotoxin core antibody levels in predicting the development of multiple organ failure in acute pancreatitis. Br J Surg (1993) 1.03
Protein synthesis in cancer patients with inflammatory response: investigations with [15N]glycine. Nutrition (1994) 1.02
Phenotypic characterization of the early cellular responses in allergic and irritant contact dermatitis. Clin Exp Immunol (1986) 1.02
Light-induced variation in phenolic levels in foliage of rain-forest plants : I. Chemical changes. J Chem Ecol (1988) 1.02
Dermcidin expression in hepatic cells improves survival without N-glycosylation, but requires asparagine residues. Br J Cancer (2006) 1.01
Urocanic acid and immunosuppression. Photochem Photobiol (1989) 1.01
Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients. Br J Cancer (1995) 1.01